← Leaderboards
James D. West
Vanderbilt University
$3,214,447
Attributed
$3,214,447
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $807.3K · FY2012–16$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$3,214,447 · 1
By mechanism
P01$3,214,447 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Nancy Joan Brown$32,445,188
- Douglas Eugene Vaughan$19,799,621
- James E Loyd$19,105,238
- Agnes B Fogo$7,762,267
- Satoru Eguchi$8,928,684
Others in their field
Top investigators on “Dose”
- Lawrence Corey · Fred Hutchinson Cancer Center$251,944,397
- Sharon A Nachman · Johns Hopkins University$213,337,729
- David Heimbrook · Leidos Biomedical Research, Inc.$146,807,554
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$134,297,561
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Peter C Adamson · National Childhood Cancer Foundation$122,197,823
Research focus
DoseEndothelial CellsConstrictionAngiotensin-Converting Enzyme InhibitorsAffectDefectAcuteAnimal ModelAnimalsAnti-InflammatoryAnti-Inflammatory AgentsAngiotensin IAngiotensin IiCytoskeletonAngiotensin Ii ReceptorAngiogenesisBlood VesselsBmpr2 GeneCapillary BedCell Culture TechniquesCell PhysiologyChronicCleaved CellEndothelium
Grant awards (6)
ACE2 Safety and Mechanism in Treatment of Pulmonarv Arterial Hypertension/Loyd$656,221
P01 · FY2016 · HL · contact PI
ACE2 Safety and Mechanism in Treatment of Pulmonarv Arterial Hypertension/Loyd$644,907
P01 · FY2015 · HL · contact PI
ACE2 Safety and Mechanism in Treatment of Pulmonarv Arterial Hypertension/Loyd$162,424
P01 · FY2015 · HL · contact PI
ACE2 Safety and Mechanism in Treatment of Pulmonarv Arterial Hypertension/Loyd$632,472
P01 · FY2014 · HL · contact PI
ACE2 Safety and Mechanism in Treatment of Pulmonarv Arterial Hypertension/Loyd$523,954
P01 · FY2013 · HL · contact PI
ACE2 Safety and Mechanism in Treatment of Pulmonarv Arterial Hypertension/Loyd$594,469
P01 · FY2012 · HL · contact PI